Cell-free DNA epigenomics to track the dynamics of organ damage and immune exhaustion during sepsis
利用游离 DNA 表观基因组学追踪脓毒症期间器官损伤和免疫衰竭的动态
基本信息
- 批准号:10274947
- 负责人:
- 金额:$ 39.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:BioinformaticsBloodBlood specimenCause of DeathCellsCessation of lifeDNA analysisDNA methylation profilingDataDiseaseImmuneIntensive Care UnitsKineticsLiteratureMediatingMethodologyMethodsMorbidity - disease rateMultiple Organ FailureOrganOutcomePatientsPlasma CellsProcessResearchSepsisSourceState HospitalsT-LymphocyteTissuesUnited StatesWorkcell free DNAepigenomicsexhaustexhaustiongenome wide methylationimprovedinnovationmortalityprogramssecondary infection
项目摘要
PROJECT SUMMARY
Sepsis is the most frequent cause of death in United States hospitals, and the number one cause of
death worldwide, responsible for 11 million deaths in 2017. Primary drivers of sepsis morbidity and
mortality are immune exhaustion leading to deadly secondary infection, and organ tissue damage
leading to multi-organ failure. Despite the critical importance of these processes in governing ultimate
sepsis outcomes, we have an incomplete understanding of their kinetics and dynamics. We thus
propose a two-pronged effort to shift our paradigm regarding sepsis dynamics through plasma cell-free
DNA analysis. Specifically, we propose to 1) track the dynamics of organ-specific damage, and 2) track
the dynamics of T cell exhaustion during sepsis. We will do this through analysis of daily blood samples
acquired from patients admitted to the intensive care unit for sepsis. Methodologically, we will achieve
these through genome-wide methylation sequencing of cell-free DNA. Bioinformatically, we will then
perform CIBERSORTx deconvolution to delineate and quantify specific cell/tissue types contributing to
plasma cell-free DNA, thus enabling us to infer organ tissues being damaged as well as T cell
exhaustion levels from both blood and tissue sources. The methods we will utilize here are highly
innovative yet feasible given recent literature and our own preliminary data. Our proposed work will
form the basis for a rich sepsis-focused research program utilizing cell-free DNA analysis to
answer major questions in the field with the potential to ultimately improve patient survival for
the deadliest disease worldwide.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aadel Chaudhuri其他文献
Aadel Chaudhuri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aadel Chaudhuri', 18)}}的其他基金
Cell-free DNA epigenomics to track the dynamics of organ damage and immune exhaustion during sepsis
利用游离 DNA 表观基因组学追踪脓毒症期间器官损伤和免疫衰竭的动态
- 批准号:
10472598 - 财政年份:2021
- 资助金额:
$ 39.38万 - 项目类别:
Cell-free DNA epigenomics to track the dynamics of organ damage and immune exhaustion during sepsis
利用游离 DNA 表观基因组学追踪脓毒症期间器官损伤和免疫衰竭的动态
- 批准号:
10680598 - 财政年份:2021
- 资助金额:
$ 39.38万 - 项目类别:
Cell-Free Nucleic Acids for Early Treatment Response Assessment of Hepatocellular Cancer
用于肝细胞癌早期治疗反应评估的无细胞核酸
- 批准号:
9897630 - 财政年份:2019
- 资助金额:
$ 39.38万 - 项目类别:
相似海外基金
THALASSEMIA DATA AND BLOOD SPECIMEN COLLECTION SYSTEM
地中海贫血数据和血液样本采集系统
- 批准号:
7607252 - 财政年份:2007
- 资助金额:
$ 39.38万 - 项目类别:
THALASSEMIA DATA AND BLOOD SPECIMEN COLLECTION SYSTEM
地中海贫血数据和血液样本采集系统
- 批准号:
7380732 - 财政年份:2006
- 资助金额:
$ 39.38万 - 项目类别:
THALASSEMIA DATA AND BLOOD SPECIMEN COLLECTION SYSTEM
地中海贫血数据和血液样本采集系统
- 批准号:
7204708 - 财政年份:2005
- 资助金额:
$ 39.38万 - 项目类别:
2D SYMBOLOGY FOR CLINICAL BLOOD SPECIMEN HANDLING
临床血液样本处理的二维符号
- 批准号:
2286334 - 财政年份:1996
- 资助金额:
$ 39.38万 - 项目类别:
CLINICAL LABORATORY BLOOD SPECIMEN INSPECTION SYSTEM
临床实验室血液标本检测系统
- 批准号:
2030324 - 财政年份:1996
- 资助金额:
$ 39.38万 - 项目类别: